Found: 3
Select item for more details and to access through your institution.
Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics.
- Published in:
- Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 981, doi. 10.1007/s12094-015-1470-0
- By:
- Publication type:
- Article
Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.
- Published in:
- 2011
- By:
- Publication type:
- Report
ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
- Published in:
- Clinical Genetics, 2008, v. 73, n. 5, p. 465, doi. 10.1111/j.1399-0004.2008.00987.x
- By:
- Publication type:
- Article